Literature DB >> 3565028

Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination.

O Simonsen, M Klaerke, A Klaerke, A V Bloch, B R Hansen, N Hald, C Hau, I Heron.   

Abstract

Immunity following diphtheria vaccination in childhood is temporary, and recent outbreaks of diphtheria in adult populations evoked interest in the effect of and side-reactions to revaccination of adults. 237 military recruits were randomly allocated to revaccination with 6 Lf tetanus toxoid or 6 Lf tetanus toxoid combined with 2 Lf or 5 Lf diphtheria toxoid. Side-reactions were recorded one week later, and antitoxin response was assessed after 4 weeks. Protective serum diphtheria antitoxin levels were attained by all subjects receiving diphtheria toxoid containing vaccines. Antibody response was related to dose, indicating a safer long-term protection by revaccination with 5 Lf diphtheria toxoid. All vaccinees, except one without documentation for primary vaccination, attained high tetanus antitoxin levels. Interference phenomena between toxoids were insignificant. Mild local reactions were reported by 22% of the vaccinees. More pronounced local reactions were experienced by 5% and systemic reactions by 3%, independent of vaccine. No serious reactions were observed. Reactions were significantly related to tetanus antitoxin response only. It was concluded that combined revaccination of adults, primary vaccinated around 20 years previously, may be performed without immune assessments.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3565028     DOI: 10.1111/j.1699-0463.1986.tb02115.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand C        ISSN: 0108-0202


  5 in total

1.  Boostering antitoxic diphtheria immunity in adults.

Authors:  H M Hasselhorn; F Hofmann; F W Tiller
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

2.  Diphtheria immunity in Flanders.

Authors:  C Matheï; P Van Damme; P Bruynseels; H Goossens; R Vranckx; A Meheus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

3.  Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites.

Authors:  J U Que; S J Cryz; R Ballou; E Fürer; M Gross; J Young; G F Wasserman; L A Loomis; J C Sadoff
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

4.  Evaluation of antidiphtheria toxin nanobodies.

Authors:  Ghada H Shaker
Journal:  Nanotechnol Sci Appl       Date:  2010-06-17

5.  Clinician awareness of tetanus-diphtheria vaccination in trauma patients: a questionnaire study.

Authors:  Young-Hoon Yoon; Sung-Woo Moon; Sung-Hyuk Choi; Young-Duck Cho; Jung-Youn Kim; Young Ho Kwak
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-05-15       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.